Musculoskeletal Injury
0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Colorado TherapeuticsCO - Louisville
1 programQuality of Life and Life Satisfaction in Pediatric and Adolescent Gymnasts Through InjuryN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Defence TherapeuticsResistance Training
Colorado TherapeuticsQuality of Life and Life Satisfaction in Pediatric and Adolescent Gymnasts Through Injury
Angeles TherapeuticsIbuprofen 600 mg
Clinical Trials (3)
Total enrollment: 1,824 patients across 3 trials
The ADAPTation to Therapeutic Resistance Training (ADAPT) Study
Start: Dec 2022Est. completion: Aug 2024150 patients
N/AUnknown
NCT05110729Colorado TherapeuticsQuality of Life and Life Satisfaction in Pediatric and Adolescent Gymnasts Through Injury
Quality of Life and Life Satisfaction in Pediatric and Adolescent Gymnasts Through Injury
Start: Nov 2021Est. completion: Nov 20261,218 patients
N/ARecruiting
NSAID Use and Healing After Tibia Fractures and Achilles Tendon Ruptures
Start: Aug 2019Est. completion: Jul 2020456 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,824 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.